T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes (Q40784739)

23 September 2017

title

T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes (English)

1 reference

23 September 2017

Turner MJ

1

1 reference

23 September 2017

Abdul-Alim CS

2

1 reference

23 September 2017

Willis RA

3

1 reference

23 September 2017

Fisher TL

4

1 reference

23 September 2017

Lord EM

5

1 reference

23 September 2017

Frelinger JG

6

1 reference

23 September 2017

publication date

1 October 2001

1 reference

Journal of Immunological Methods

23 September 2017

published in

1 reference

23 September 2017

volume

256

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

107-119

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Differential epitope expression of Ly-48 (mouse leukosialin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

The cell biology of antigen processing and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

H-2Dd exploits a four residue peptide binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Structures of an MHC class II molecule with covalently bound single peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Identification of self peptides bound to purified HLA-B27

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Chemistry of peptides associated with MHC class I and class II molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

MHC ligands and peptide motifs: first listing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Efficient in vivo induction of CTL by cell-associated covalent H-2Kd-peptide complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Sequence analysis of peptides bound to MHC class II molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

LacZ inducible, antigen/MHC-specific T cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Antigen analogs/MHC complexes as specific T cell receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

Pathways for the processing and presentation of antigens to T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900436-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-1759(01)00436-7

1 reference

23 September 2017

1 reference